BuMA® Biodegradable-Drug-Coating Coronary Stent System

 
 
Unit Price NegotiableCompare
Inquiry ing
Browse 8
Place of Dispatch Global付款后3天内
Expiration Date No Expiration
Update 2026-10-13 00:33
 
Supplier
Add Follow0

Sino Medical Sciences Technology Inc.

Corporate 企业会员第1年
Profile Certified
Membership LevelCorporate 企业会员
  • China
  • 上次登录 05-08 11:10 •
  • sinomed (Mr.)  
Content

Robust polymer coating

Through an electro-chemical process, eG Coating™ is synthesized onto the surface of the stent, creating a filament-like structure that interdigitates into the matrix polymer layer. This technique creates a robust coating integrity that is resistant to flaking, pealing and cracking.

Lower drug dose and optimized release kinetics

Sirolimus dose and release kinetic were designed to hindering neointimal hyperplasia, while allowing for an earlier return of functional healing.

Rapid absorption of polymer

Following the absorption of the PLGA polymer, only the stent is left behind with eG Coating™. No inflammatory residue remains in the patient after two months.

Flexible stent platform

The overall stent design and helical pattern of the S-Links allow for exceptional flexibility and conformability of the stent.

1.Track test was performed in a 37°C water bath with an ASTM tortuous path model. Data on file.

2.Data based on in vitro tests. Data on file.

3.Rizas, Konstantinos D., and Julinda Mehilli. 2016. Circulation: Cardiovascular Interventions 9 (6): 1–13.

Compliance Chart

Product Specifications

ReportFavorite 0
More>Other Products
BuMA Supreme® Drug Coated Coronary Stent System TRADENT™ Coronary Scoring Balloon Catheter NOVA NEO™ Intracranial Drug-eluting Stent System HT Supreme™ Drug Coated Coronary Stent System
More>Q&A Message
No Q&A available , Click here to ask a question
Home  |  About TOPimd  |  Contact Us  |  Terms of Use  |  Privacy Notice  |  Ranking service  |  AD service  |  GuestBook  |  Help  |  Sitemap  |  Report
粤ICP备20002052号-5Support Line : +86-18503018802(Wechat)